Dörthe Schaue's research while affiliated with University of California, Los Angeles and other places

Publications (71)

Article
Ionizing radiation (IR) can reprogram proteasome structure and function in cells and tissues. In this article, we show that IR can promote immunoproteasome synthesis with important implications for Ag processing and presentation and tumor immunity. Irradiation of a murine fibrosarcoma (FSA) induced dose-dependent de novo biosynthesis of the immunop...
Article
Full-text available
Heart disease is a significant adverse event caused by radiotherapy for some cancers. Identifying the origins of radiogenic heart disease will allow therapies to be developed. Previous studies showed non-targeted effects manifest as fibrosis in the non-irradiated heart after 120 days following targeted X-irradiation of the kidneys with 10 Gy in WAG...
Article
Purpose/Objective(s) Undifferentiated pleomorphic sarcoma (UPS) responds more frequently to immune checkpoint blockade (ICB) than other sarcoma subtypes, but most patients do not respond. To elicit de novo immune responses, we targeted the myeloid-rich tumor microenvironment of UPS. Myeloid cells are highly plastic cells that accumulate in tumors a...
Article
Full-text available
Nuclear factor erythroid 2-related factor 2 (NRF2) is recognized as a master transcription factor that regulates expression of numerous detoxifying and antioxidant cytoprotective genes. In fact, models of NRF2 deficiency indicate roles not only in redox regulation, but also in metabolism, inflammatory/autoimmune disease, cancer, and radioresistancy...
Article
Full-text available
Purpose: This review is focused on radium and radionuclides in its decay chain in honor of Marie Curie, who discovered this element. Materials and methods: We conglomerated current knowledge regarding radium and its history predating our present understanding of this radionuclide. Results: An overview of the properties of radium and its dose a...
Chapter
Irradiated tissues engage the immune system on many levels. The general assumption is that the initial damage alerts immune cells through universal danger sensing and signaling pathways that are pro-oxidant, pro-inflammatory at first, before morphing into an anti-oxidant, anti-inflammatory counter response. The perpetuating nature of the inflammato...
Article
Full-text available
This is Editorial for the special issue “Ionizing Radiation and Human Health: A Multifaceted Relationship” in Frontiers in Public Health and Frontiers in Oncology, highlighting each of 27 contributing articles.
Article
Full-text available
Purpose: As part of the special issue on ‘Women in Science’, this review offers a perspective on past and ongoing work in the field of normal (non-cancer) tissue radiation biology, highlighting the work of many of the leading contributors to this field of research. We discuss some of the hypotheses that have guided investigations, with a focus on s...
Article
Full-text available
We previously reported several vignettes on types and classes of drugs able to mitigate acute and, in at least one case, late radiation syndromes in mice. Most of these had emerged from high throughput screening (HTS) of bioactive and chemical drug libraries using ionizing radiation-induced lymphocytic apoptosis as a readout. Here we report the ful...
Article
Full-text available
Hundreds of ongoing clinical trials combine radiation therapy, mostly delivered as stereotactic body radiotherapy (SBRT), with immune checkpoint blockade. However, our understanding of the effect of radiotherapy on the intratumoral immune balance is inadequate, hindering the optimal design of trials that combine radiation therapy with immunotherapy...
Article
Full-text available
Ionizing radiation interacts with the immune system in many ways with a multiplicity that mirrors the complexity of the immune system itself: namely the need to maintain a delicate balance between different compartments, cells and soluble factors that work collectively to protect, maintain, and restore tissue function in the face of severe challeng...
Article
Full-text available
Acute radiation exposure of the thorax can lead to late serious, and even life-threatening, pulmonary and cardiac damage. Sporadic in nature, late complications tend to be difficult to predict, which prompted this investigation into identifying non-invasive, tissue-specific biomarkers for the early detection of late radiation injury. Levels of circ...
Article
Full-text available
The purpose of this study was to determine the dynamic contributions of different immune cell subsets to primary and abscopal tumor regression after hypofractionated radiation therapy (hRT) and the impact of anti-PD-1 therapy. A bilateral syngeneic FSA1 fibrosarcoma model was used in immunocompetent C3H mice, with delayed inoculation to mimic prima...
Article
Full-text available
339 Background: Stereotactic Body Radiotherapy (SBRT) delivers high dose per fraction radiotherapy to targets with high precision. Such hypofractionated RT appears to act as an immune adjuvant, altering the tumor infiltrating immune landscape and enriching it for lymphocytes as numerous preclinical investigations would suggest. Based on this hypoth...
Article
Full-text available
Normal tissue responses to ionizing radiation have been a major subject for study since the discovery of x‐rays at the end of the 19th century. Shortly thereafter, time‐dose relationships were established for some normal tissue endpoints that led to investigations into how the size of dose per fraction and quality of radiation affected outcome. The...
Article
Full-text available
Background: We previously reported the results of a multicentric prospective randomized trial of chemo-refractory metastatic breast cancer patients testing the efficacy of two doses of TGFβ blockade during radiotherapy. Despite a lack of objective responses to the combination, patients who received a higher dose of TGFβ blocking antibody fresolimu...
Article
Full-text available
2683 Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with Unfavorable and High-Risk Non-Metastatic Prostate Cancer: Feasibility And Safety N.G. Nickols,1 A.U. Kishan,1 N. Kane,2 S. Diaz-Perez,3 E. Ganapathy,2 R. Nazarian,2 C. Felix,2 C. Mathis,2 J.Y. Kwak,2 V. Basehart,4 N. Zomorodian,2 C.R. King,1...
Article
Full-text available
Background Various proinflammatory cytokines can be detected within the melanoma tumor microenvironment. Interleukin 32 (IL32) is produced by T cells, NK cells and monocytes/macrophages, but also by a subset of melanoma cells. We sought to better understand the biology of IL32 in human melanoma. Methods We analyzed RNA sequencing data from 53 in-h...
Article
Objective: Exposure to lethal doses of radiation has severe effects on normal tissues. Exposed individuals experience a plethora of symptoms in different organ systems including the gastrointestinal (GI) tract, summarized as Acute Radiation Syndrome (ARS). There are currently no approved drugs for mitigating GI-ARS. A recent high-throughput screen...
Article
Full-text available
Intensive research is underway to find new agents that can successfully mitigate the acute effects of radiation exposure. This is primarily in response to potential counterthreats of radiological terrorism and nuclear accidents but there is some hope that they might also be of value for cancer patients treated with radiation therapy. Research into...
Article
Résumé En radiothérapie, le traitement est adapté à chaque individu afin de protéger les organes à risque mais délivre le plus souvent une dose standardisée pour un type histologique et une localisation tumorale donnés. Les seuls biomarqueurs à l’étude pour un traitement individualisé sont le statut selon les papillomavirus humains (HPV), avec des...
Article
Innovation and progress in radiation oncology depend on discovery and insights realized through research in radiation biology. Radiobiology research has led to fundamental scientific insights, from the discovery of stem/progenitor cells to the definition of signal transduction pathways activated by ionizing radiation that are now recognized as inte...
Article
Full-text available
Our ability to use ionizing radiation as an energy source, as a therapeutic agent, and, unfortunately, as a weapon, has evolved tremendously over the past 120 years, yet our tool box to handle the consequences of accidental and unwanted radiation exposure remains very limited. We have identified a novel group of small molecule compounds with a 4-ni...
Article
Full-text available
The advent and success of immune checkpoint inhibitors (ICIs) in cancer treatment has broadened the spectrum of tumours that might be considered "immunogenic" and susceptible to immunotherapeutic (IT) intervention. Not all cancer types are sensitive, and not all patients with any given type respond. Combination treatment of ICIs with an established...
Article
Full-text available
The coming of age for immunotherapy (IT) as a genuine treatment option for cancer patients through the development of new and effective agents, in particular immune checkpoint inhibitors, has led to a huge renaissance of an old idea, namely to harness the power of the immune system to that of radiation therapy (RT). It is not an overstatement to sa...
Article
s: AACR Special Conference on Tumor Immunology and Immunotherapy; October 20-23, 2016; Boston, MA Purpose: This is a pilot study combining focal irradiation and systemic TGFβ blockade in metastatic breast cancer. The rationale for using TGFβ blockade was to limit tumor growth and further spread as well as to curb systemic immune suppression. Combi...
Article
Importance: There is a significant need to find biomarkers of response to radiotherapy and cetuximab in locally advanced head and neck squamous cell carcinoma (HNSCC) and biomarkers that predict altered immunity, thereby enabling personalized treatment. Objectives: To examine whether the Kirsten rat sarcoma viral oncogene homolog (KRAS)-variant,...
Article
Full-text available
Background: Squamous cell carcinoma of the head and neck (SCCHN) is a radiation-sensitive disease. Standard frontline treatment of locally advanced SCCHN entails concurrent chemotherapy with radiation. Treatment of relapsed or metastatic SCCHN often utilizes re-irradiation to the primary tumor for local control. However, there is no standard system...
Article
Full-text available
The past 20 years have seen dramatic changes in the delivery of radiation therapy, but the impact of radiobiology on the clinic has been far less substantial. A major consideration in the use of radiotherapy has been on how best to exploit differences between the tumour and host tissue characteristics, which in the past has been achieved empiricall...
Article
The immune system has the power to modulate the expression of radiation-induced normal and tumor tissue damage. On the one hand, it can contribute to cancer cure, and on the other hand, it can influence acute and late radiation side effects, which in many ways resemble acute and chronic inflammatory disease states. The way radiation-induced inflamm...
Article
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Background: Patients with glioblastoma multiforme (GBM) despite being treated with gross total resection and post-operative temozolomide (TMZ) plus radiation therapy (RT), will almost always develop tumor recurrence. Hypothesis and objective: We hypothesize GBM stem cells (G...
Article
Full-text available
Anti-tumor immune response in lung cancer patients may be evoked by intra-tumoral (IT) administration of autologous dendritic cells (DC), transduced with a replication-deficient adenoviral (Ad) vector to express the secondary lymphoid chemokine (SLC/CCL21) gene. Here, we evaluated tumor specific immune response after CCL21 gene-modified DC (Ad-CCL2...
Article
Accumulating data support the concept that ionizing radiation therapy (RT) has the potential to convert the tumor into an in situ, individualized vaccine; however this potential is rarely realized by RT alone. Transforming growth factor β (TGFβ) is an immunosuppressive cytokine that is activated by RT and inhibits the antigen-presenting function of...
Article
Full-text available
Glioblastoma stem cells (GSC) are a significant cell model for explaining brain tumor recurrence. However, mechanisms underlying their radiochemoresistance remain obscure. Here we show that most clonogenic cells in GSC cultures are sensitive to radiation treatment (RT) with or without temozolomide (TMZ). Only a few single cells survive treatment an...
Article
This study used chloroquine to direct radiation-induced tumor cell death pathways to harness the antitumor activity of the immune system. Chloroquine given immediately after tumor irradiation increased the cure rate of MCaK breast cancer in C3H mice. Chloroquine blocked radiation-induced autophagy and drove MCaK cells into a more rapid apoptotic an...
Article
Full-text available
Background and purpose: Current treatment of head and neck cancer generally involves a combination of surgery, radiation and chemotherapy. Clinical outcomes for many patients remain suboptimal, and novel therapeutic strategies are needed. Targeted inhibition of poly(ADP-Ribose) polymerase (PARP), a key DNA repair enzyme, has been actively investiga...
Chapter
Full-text available
The delivery of external beam radiation therapy (RT) for cancer with intent to cure has been optimized over the last 80 years and standardized to a protocol with doses fractionated into around 2 Gy amounts delivered daily five times per week to the tumor with a relatively homogeneous field and with the total dose being determined by what adjacent l...
Article
Full-text available
Cytokines function in many roles that are highly relevant to radiation research. This review focuses on how cytokines are structurally organized, how they are induced by radiation, and how they orchestrate mesenchymal, epithelial and immune cell interactions in irradiated tissues. Pro-inflammatory cytokines are the major components of immediate ear...
Article
Full-text available
There is compelling evidence that lymphocytes are a recurring feature in radiation damaged normal tissues, but assessing their functional significance has proven difficult. Contradictory roles have been postulated in both tissue pathogenesis and protection, although these are not necessarily mutually exclusive as the immune system can display what...
Article
Full-text available
Radiation therapy (RT) can extend its influence in cancer therapy beyond what can be attributed to in-field cytotoxicity by modulating the immune system. While complex, these systemic effects can help tip the therapeutic balance in favor of treatment success or failure. Engagement of the immune system is generally through recognition of damage-asso...
Article
Full-text available
Cells often autofluoresce in response to UV radiation excitation and this can reflect critical aspects of cellular metabolism. Here we report that many different human and murine cell types respond to ionizing radiation with a striking rise in autofluorescence that is dependent on dose and time. There was a highly reproducible fluorescent shift at...
Article
Technologic advances have led to increased clinical use of higher-sized fractions of radiation dose and higher total doses. How these modify the pathways involved in tumor cell death, normal tissue response, and signaling to the immune system has been inadequately explored. Here we ask how radiation dose and fraction size affect antitumor immunity,...
Article
Full-text available
Stereotactic radiation approaches are gaining more popularity for the treatment of intracranial as well as extracranial tumors in organs such as the liver and lung. Technology, rather than biology, is driving the rapid adoption of stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), in the clinic due...
Article
Immunotherapy could be a useful adjunct to standard cytotoxic therapies such as radiation in patients with micrometastatic disease, although successful integration of immunotherapy into treatment protocols will require further understanding of how standard therapies affect the generation of antitumor immune responses. This study was undertaken to e...
Article
Full-text available
The body senses "danger" from "damaged self" molecules through members of the same receptor superfamily it uses for microbial "non-self", triggering canonical signaling pathways that lead to the generation of acute inflammatory responses. For this reason, the biology of normal tissue responses to moderate and clinically relevant doses of radiation...
Article
Background/Aim: We attempted to develop a humanized mouse model for prostate cancer to study immune recognition and responses to human prostate-tumor antigens in mice. Our study was based on cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) tumors. TRAMP cells were modified to express a chimeric MHC I molecule comprisi...
Article
Radiation therapy affects the immune system. In addition to killing radiosensitive immune cells, it can induce functional changes in those cells that survive. Our recent studies showed that the exposure of dendritic cells (DCs) to radiation in vitro influences their ability to present tumour antigen in vivo. Here we show that local radiation therap...
Article
Full-text available
The goal of this study was to determine if radiation therapy (RT) of human cancer enhances or diminishes tumor-specific T-cell reactivity. This is important if immunotherapy is to be harnessed to improve the outcome of cancer radiotherapy. Lymphocytes were isolated from colorectal cancer (CRC) patients before, during, and after presurgical chemorad...
Article
Full-text available
3'-[F-18]fluoro-3'-deoxythymidine (FLT) traces thymidine phosphorylation catalyzed by thymidine kinase during cell proliferation. Knowing the rate of cell proliferation during cancer treatment, such as radiation therapy, would be valuable in assessing whether tumor recurrence is likely and might indicate the need for additional treatments. However,...
Article
The power of ionizing radiation as a therapeutic modality is based in large part on two basic principles. One is the use of sophisticated delivery systems that minimize the dose to normal tissues and maximize the dose to the tumor, an approach epitomized by the advent of intensity-modulated radiation therapy. Intensitymodulated radiation therapy ha...
Article
Low-dose radiotherapy (RT) has often been used effectively for the treatment of a variety of benign diseases, particularly those with acute inflammatory features. Here we report findings on radiation treatment of acute inflammation using a murine carrageenin air pouch model. Air pouches raised on the dorsal surface of mice were injected with lambda...
Article
Local irradiation with a dose of around 0.5 Gy is an effective treatment of acute necrotizing inflammations. The hypothesis that low doses of X-rays modulate the oxidative burst in activated macrophages, which plays a major role in the acute inflammatory process, was tested. Murine RAW 264.7 macrophages were stimulated with LPS/gammaIFN, PMA or zym...

Citations

... Of note, irradiation generated a novel set of MHC class I-binding peptides. Upregulation of immunoproteasome subunits, which are involved in the production of peptides with higher binding capacity to MHC class I molecules than standard proteasome, may partly explain the increased neoepitopes following RT [113]. Lhuillier et al. reported direct evidence that the expression of immunogenic neoantigens on murine breast cancer cells is increased by RT [114]. ...
... The engagement of other components of the immune system may be necessary, in addition to macrophages, to cause kidney pathology following irradiation with components of GCRs. In support of this suggestion, irradiation of the kidneys with 10 Gy of X-rays in WAG/ RijCmcr rats resulted in infiltration of T cells, natural killer cells, and macrophages is associated with nephropathy [25]. The 270 day follow up period used here may also have been of insufficient duration to detect other changes in immune cell recruitment to the kidney needed to elicit the development of structural changes in the kidney and a greater increase in blood pressure. ...
... Reactive oxygen species (ROS) can contribute to carcinogenesis directly by inducing mutations in proto-oncogenes and tumor suppressor genes and indirectly by activating kinases that induce growth-promoting cellular functions (Cerutti, 1985;Son et al., 2013;Waris and Ahsan, 2006). Activation of the NRF2 pathway induces the transcription of genes encoding antioxidant and detoxification enzymes that counteract dangerous accumulation of ROS (Kwak et al., 2003;Lee et al., 2003) and protects cells from transformation (Hao et al., 2020;Schaue et al., 2022;Wang et al., 2022b;Zhang and Gordon, 2004). Several of these protective genes include GSTP1 (Fang et al., 2020;Zhou et al., 2022), TXN, NQO1, and HMOX1 (Tonelli et al., 2018). ...
... After the discovery and isolation of 226 Ra from uraninite (pitchblende) in 1898 by Marie and Pierre Curie, 3 it rapidly gained popularity for use in a myriad of consumer products that aimed to exploit its radioactivity. 4 These products, which ranged from radioluminescent paint for watch dials to quack health and beauty items, were eventually recognized as being toxic. This toxicity, however, also rendered Ra valuable in medicine. ...
... These data may support that TNF-α alteration was tumor-specific. This finding was supported by a loop between radio-induced inflammation, mobilization of immune cells and sustained tissular damage, mediated by DNA damage and SASP factors following irradiation [69]. However, our results were in discordance with previous studies that reported persistent systemic inflammation in individuals with a history of IR exposure [70]. ...
... In a recent study, Singh and colleagues analyzed metabolic and lipidomic profiles in the serum of NHPs (7.2 Gy of c radiation) after treatment of a candidate drug, Ex-Rad (ON01210), which showed significant alterations in biochemical pathways towards the recovery of radiationinjured organs (199). Several other studies and reviews were focused on repurposing of drugs as radiomitigators (198)(199)(200)(201)(202). ...
... At low doses, the IS may be affected, leading to accelerated immune aging and increased risk of various health issues, such as age-related degenerative disorders and cancer. On the other hand, LDR therapy has been found to have positive effects on chronic inflammatory and degenerative diseases, including antiinflammatory and pain-relieving properties [23]. Several studies have confirmed that the effect of LDR on innate and adaptive Frontiers in Physics frontiersin.org ...
... Undoubtedly, it should be taken into consideration that the different treatment approaches in PCa may affect the rates of immune subpopulations; however, up-to-date studies have mainly focused on the tumor microenvironment. For example, stereotactic body radiation therapy (SBRT) has been found to alter the immune environment within PCa tumors, causing increases in the relative abundance of myeloid cells and decreases in CD8+ T cells [28,29]. Nonetheless, there has not been extensive research on the effects on systemic circulation, although it is known that radiotherapy promotes immunogenic cell death by remodeling the tumor microenvironment and induces immune responses by enhancing antigen cross-presentation and CD8+ T cell response [30,31]. ...
... In light of historical data on the use of LD-RT to treat various forms of pneumonia, 8 exposure of the lungs to low/moderate radiation dose(s) has been discussed as a way to mitigate inflammation and eventually prevent the development of the cytokine storm in patients with COVID-19. 9 Despite controversy on this use of LD-RT (see, for example, Schaue and McBride and Rodel et al), 10,11 several clinical trials are underway (see Yu et al for a recent review of clinical trials). 12 This topic, therefore, requires further investigation to identify patients who would benefit from LD-RT application while considering the potential risk for radiationinduced cancer and noncancer disease. ...
... pneumonitis and minimal pulmonary fibrosis [12][13][14] , and typically use animal survival as the primary experimental endpoint 15 , instead of incidence and severity of pneumonitis, which is more human-relevant. Currently, non-human primate (NHP) models are considered the goldstandard for radiation injury 16,17 , but their use is limited by short supply, long breeding periods, high costs, and serious ethical concerns 18,19 . ...